Skip to content

LIEPHARM

Absorbed by PHARMACIE BUSTIN KBO/BCE: BE 0568.953.597

Lifetime

9 annual accounts with figures on one time axis
peak €213,217 (2023)
€213,217▲ 20.0%
lowest -€43,824 (2016)
€45,375▼ 10.2%
peak €281,357 (2023)
€281,357▲ 19.2%
€1.2m▼ 3.1%
peak 3 FTE (2022)
3 FTEunchanged
Board6 names since 2015
1 director
Owners
100%
Documentsfilings and deeds
25-07-20246 days before the deadline
2023financial year
Gross margin from €177,672 to €213,217Equity from €235,982 to €281,357

Key points

from the 2023 annual accounts, the last ones filed

Profit

7 years
201820192020202120222023

7 profitable years in a row. Profit 2023: €45,375.

Debts

€1.2m 81% of the balance sheet
Financial debts 3%Suppliers 66%Taxes and wages 3%Other 28%

Of this, €1.2m falls due within a year.

Filings

9 annual accounts 4 late
AprilJune31 JulyOctober20152020

The 2016 accounts came latest: 30 days after the end of the period.

Board and ownership

Daily manager
Director,
Director
Auditor,
Board & ownership

Recent changes

Merger: absorbed by PHARMACIE BUSTIN Dissolution of the company · Dissolved without liquidation · holds 100% of the shares · General meeting of 28-06-2024 · Gazette deed
Merger proposal: to be absorbed by PHARMACIE BUSTIN holds all the shares · Gazette deed
Registered office moved to Verviers New registered office: rue de Mangombroux 161, 4800 VERVIERS · Resignations: (director) and (director) · Appointments: , (statutory auditor) and (daily management delegate) · General meeting of 10-01-2024 · Gazette deed
Changes of role: (director) and (director) Director discharge: · Director discharge: · General meeting of 29-11-2023 · Gazette deed
All 20 events

Official details

Source: KBO
Status
Absorbed by PHARMACIE BUSTINmerger by absorption, June 2024
Activity
No activity registered in the KBO
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2023

≈ €540,000estimated
€1.5m▲ 0.5%
Employeeson 31-12-2023
3=
Filing
Filed on 25-07-2024
Financials

Insights on LIEPHARM

Absorbed by PHARMACIE BUSTIN in June 2024. The last annual accounts are for financial year 2023. The company was dissolved without liquidation.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about LIEPHARM

What is the company number of LIEPHARM?
The company number of LIEPHARM is 0568.953.597. The VAT number is the same number with BE in front: BE 0568.953.597.
What is the legal form of LIEPHARM?
Legal form of LIEPHARM: SRL.
Is LIEPHARM still active?
No. LIEPHARM is inactive in the KBO register.Company details
How many employees did LIEPHARM have?
LIEPHARM had an average of 3 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of LIEPHARM?
The turnover in financial year 2023 is ≈ €540,000. This figure is estimated from the gross margin of €213,217 and 1,653 comparable companies of the same size. It probably lies between €330,000 and €1.0m. It is a rough estimate.
Is LIEPHARM profitable?
In financial year 2023, LIEPHARM made a profit of €45,375.
Where can I find the annual accounts of LIEPHARM?
LIEPHARM filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2023.

Next steps

Keep this company with today's facts in a case file.